78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Edwards Lifesciences's P/S ratio is 9.26: its market cap of 61.79B USD over revenue of 6.67B USD in the last twelve months.
- Today
- 9.26
- Average, 5 years
- 9.26
- Low, 5 years
- 6.99
- High, 5 years
- 16.00
P/S ratio = market cap ÷ revenue (last 12 months) = 61.79B ÷ 6.67B = 9.26
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 9.26 | 61.79B | 6.67B | |
| FY2025 | 31 Dec 2025 | 8.22 | 49.85B | 6.07B |
| FY2024 | 31 Dec 2024 | 8.13 | 44.25B | 5.44B |
| FY2023 | 31 Dec 2023 | 9.23 | 46.26B | 5.01B |
| FY2022 | 31 Dec 2022 | 8.58 | 46.18B | 5.38B |
| FY2021 | 31 Dec 2021 | 15.43 | 80.75B | 5.23B |
| FY2020 | 31 Dec 2020 | 12.95 | 56.80B | 4.39B |
| FY2019 | 31 Dec 2019 | 11.18 | 48.59B | 4.35B |
| FY2018 | 31 Dec 2018 | 8.61 | 32.04B | 3.72B |
| FY2017 | 31 Dec 2017 | 6.92 | 23.77B | 3.44B |
| FY2016 | 31 Dec 2016 | 6.73 | 19.96B | 2.96B |
| FY2015 | 31 Dec 2015 | 6.83 | 17.02B | 2.49B |
| FY2014 | 31 Dec 2014 | 5.84 | 13.57B | 2.32B |
| FY2013 | 31 Dec 2013 | 3.59 | 7.35B | 2.05B |
| FY2012 | 31 Dec 2012 | 5.45 | 10.36B | 1.90B |
| FY2011 | 31 Dec 2011 | 4.83 | 8.10B | 1.68B |
| FY2010 | 31 Dec 2010 | 6.35 | 9.19B | 1.45B |
| FY2009 | 31 Dec 2009 | 3.70 | 4.89B | 1.32B |
| FY2008 | 31 Dec 2008 | 2.48 | 3.07B | 1.24B |
| FY2007 | 31 Dec 2007 | 2.42 | 2.64B | 1.09B |
| FY2006 | 31 Dec 2006 | 2.65 | 2.75B | 1.04B |
| FY2005 | 31 Dec 2005 | 2.49 | 2.48B | 997.90M |
| FY2004 | 31 Dec 2004 | 2.64 | 2.46B | 931.50M |
| FY2003 | 31 Dec 2003 | 2.07 | 1.78B | 860.50M |
| FY2002 | 31 Dec 2002 | 2.13 | 1.50B | 704.00M |
| FY2001 | 31 Dec 2001 | 2.35 | 1.63B | 692.00M |
| FY2000 | 31 Dec 2000 | 1.28 | 1.03B | 804.00M |
| FY1999 | 31 Dec 1999 | 1.06 | 958.47M | 905.00M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 7.45 | 49.75B | 6.67B |
| Q2 FY2026 | 30 Jun 2026 | 8.01 | 52.14B | 6.51B |
| Q1 FY2026 | 31 Mar 2026 | 7.36 | 46.38B | 6.30B |
| Q4 FY2025 | 31 Dec 2025 | 8.15 | 49.48B | 6.07B |
| Q3 FY2025 | 30 Sept 2025 | 7.73 | 45.47B | 5.88B |
| Q2 FY2025 | 30 Jun 2025 | 8.08 | 45.91B | 5.69B |
| Q1 FY2025 | 31 Mar 2025 | 7.68 | 42.54B | 5.54B |
| Q4 FY2024 | 31 Dec 2024 | 8.00 | 43.66B | 5.46B |
| Q3 FY2024 | 30 Sept 2024 | 7.38 | 39.41B | 5.34B |
| Q2 FY2024 | 30 Jun 2024 | 10.40 | 54.34B | 5.23B |
| Q1 FY2024 | 31 Mar 2024 | 11.08 | 56.70B | 5.12B |
| Q4 FY2023 | 31 Dec 2023 | 8.79 | 46.15B | 5.25B |
| Q3 FY2023 | 30 Sept 2023 | 7.89 | 42.05B | 5.33B |
| Q2 FY2023 | 30 Jun 2023 | 10.59 | 57.25B | 5.41B |
| Q1 FY2023 | 31 Mar 2023 | 9.14 | 50.26B | 5.50B |
| Q4 FY2022 | 31 Dec 2022 | 8.50 | 45.73B | 5.38B |
| Q3 FY2022 | 30 Sept 2022 | 9.55 | 51.21B | 5.36B |
| Q2 FY2022 | 30 Jun 2022 | 11.03 | 59.04B | 5.36B |
| Q1 FY2022 | 31 Mar 2022 | 13.67 | 73.23B | 5.36B |
| Q4 FY2021 | 31 Dec 2021 | 15.45 | 80.85B | 5.23B |
| Q3 FY2021 | 30 Sept 2021 | 13.86 | 70.60B | 5.09B |
| Q2 FY2021 | 30 Jun 2021 | 13.09 | 64.45B | 4.93B |
| Q1 FY2021 | 31 Mar 2021 | 11.65 | 52.12B | 4.47B |
| Q4 FY2020 | 31 Dec 2020 | 12.97 | 56.88B | 4.39B |
| Q3 FY2020 | 30 Sept 2020 | 11.37 | 49.66B | 4.37B |
| Q2 FY2020 | 30 Jun 2020 | 9.75 | 42.12B | 4.32B |
| Q1 FY2020 | 31 Mar 2020 | 8.76 | 39.27B | 4.48B |
| Q4 FY2019 | 31 Dec 2019 | 11.20 | 48.71B | 4.35B |
| Q3 FY2019 | 30 Sept 2019 | 11.03 | 45.79B | 4.15B |
| Q2 FY2019 | 30 Jun 2019 | 9.73 | 38.56B | 3.96B |
| Q1 FY2019 | 31 Mar 2019 | 10.34 | 39.50B | 3.82B |
| Q4 FY2018 | 31 Dec 2018 | 8.56 | 31.87B | 3.72B |
| Q3 FY2018 | 30 Sept 2018 | 9.83 | 35.70B | 3.63B |
| Q2 FY2018 | 30 Jun 2018 | 8.59 | 30.50B | 3.55B |
| Q1 FY2018 | 31 Mar 2018 | 8.51 | 29.33B | 3.45B |
| Q4 FY2017 | 31 Dec 2017 | 6.92 | 23.76B | 3.44B |
| Q3 FY2017 | 30 Sept 2017 | 6.97 | 23.10B | 3.31B |
| Q2 FY2017 | 30 Jun 2017 | 7.70 | 24.89B | 3.23B |
| Q1 FY2017 | 31 Mar 2017 | 6.31 | 19.87B | 3.15B |
| Q4 FY2016 | 31 Dec 2016 | 6.76 | 20.02B | 2.96B |
| Q3 FY2016 | 30 Sept 2016 | 8.96 | 25.70B | 2.87B |
| Q2 FY2016 | 30 Jun 2016 | 7.71 | 21.16B | 2.74B |
| Q1 FY2016 | 31 Mar 2016 | 7.23 | 18.80B | 2.60B |
| Q4 FY2015 | 31 Dec 2015 | 6.83 | 17.04B | 2.49B |
| Q3 FY2015 | 30 Sept 2015 | 6.27 | 15.30B | 2.44B |
| Q2 FY2015 | 30 Jun 2015 | 6.30 | 15.33B | 2.43B |
| Q1 FY2015 | 31 Mar 2015 | 6.42 | 15.36B | 2.39B |
| Q4 FY2014 | 31 Dec 2014 | 5.89 | 13.68B | 2.32B |
| Q3 FY2014 | 30 Sept 2014 | 4.85 | 10.87B | 2.24B |
| Q2 FY2014 | 30 Jun 2014 | 4.26 | 9.06B | 2.13B |
| Q1 FY2014 | 31 Mar 2014 | 3.82 | 7.91B | 2.07B |
| Q4 FY2013 | 31 Dec 2013 | 3.51 | 7.18B | 2.05B |
| Q3 FY2013 | 30 Sept 2013 | 3.83 | 7.73B | 2.02B |
| Q2 FY2013 | 30 Jun 2013 | 3.83 | 7.55B | 1.97B |
| Q1 FY2013 | 31 Mar 2013 | 4.84 | 9.37B | 1.94B |
| Q4 FY2012 | 31 Dec 2012 | 5.46 | 10.37B | 1.90B |
| Q3 FY2012 | 30 Sept 2012 | 6.85 | 12.47B | 1.82B |
| Q2 FY2012 | 30 Jun 2012 | 6.65 | 11.87B | 1.78B |
| Q1 FY2012 | 31 Mar 2012 | 4.78 | 8.29B | 1.73B |
| Q4 FY2011 | 31 Dec 2011 | 4.81 | 8.07B | 1.68B |
| Q3 FY2011 | 30 Sept 2011 | 4.98 | 8.17B | 1.64B |
| Q2 FY2011 | 30 Jun 2011 | 6.35 | 10.01B | 1.58B |
| Q1 FY2011 | 31 Mar 2011 | 6.62 | 10.00B | 1.51B |
| Q4 FY2010 | 31 Dec 2010 | 6.35 | 9.18B | 1.45B |
| Q3 FY2010 | 30 Sept 2010 | 5.44 | 7.62B | 1.40B |
| Q2 FY2010 | 30 Jun 2010 | 4.61 | 6.35B | 1.38B |
| Q1 FY2010 | 31 Mar 2010 | 4.15 | 5.60B | 1.35B |
| Q4 FY2009 | 31 Dec 2009 | 3.71 | 4.90B | 1.32B |
| Q3 FY2009 | 30 Sept 2009 | 3.07 | 3.94B | 1.28B |
| Q2 FY2009 | 30 Jun 2009 | 3.03 | 3.82B | 1.26B |
| Q1 FY2009 | 31 Mar 2009 | 2.71 | 3.40B | 1.25B |
| Q4 FY2008 | 31 Dec 2008 | 2.48 | 3.07B | 1.24B |
| Q3 FY2008 | 30 Sept 2008 | 2.65 | 3.23B | 1.22B |
| Q2 FY2008 | 30 Jun 2008 | 2.92 | 3.44B | 1.18B |
| Q1 FY2008 | 31 Mar 2008 | 2.22 | 2.50B | 1.12B |
| Q4 FY2007 | 31 Dec 2007 | 2.39 | 2.61B | 1.09B |
| Q3 FY2007 | 30 Sept 2007 | 2.66 | 2.83B | 1.06B |
| Q2 FY2007 | 30 Jun 2007 | 2.70 | 2.84B | 1.05B |
| Q1 FY2007 | 31 Mar 2007 | 2.81 | 2.94B | 1.04B |
| Q4 FY2006 | 31 Dec 2006 | 2.61 | 2.71B | 1.04B |
| Q3 FY2006 | 30 Sept 2006 | 2.65 | 2.71B | 1.02B |
| Q2 FY2006 | 30 Jun 2006 | 2.63 | 2.67B | 1.01B |
| Q1 FY2006 | 31 Mar 2006 | 2.56 | 2.58B | 1.01B |
| Q4 FY2005 | 31 Dec 2005 | 2.49 | 2.48B | 997.90M |
| Q3 FY2005 | 30 Sept 2005 | 2.70 | 2.66B | 985.30M |
| Q2 FY2005 | 30 Jun 2005 | 2.65 | 2.56B | 969.20M |
| Q1 FY2005 | 31 Mar 2005 | 2.72 | 2.57B | 945.60M |
| Q4 FY2004 | 31 Dec 2004 | 2.64 | 2.46B | 931.50M |
| Q3 FY2004 | 30 Sept 2004 | 2.18 | 2.00B | 918.50M |
| Q2 FY2004 | 30 Jun 2004 | 2.30 | 2.07B | 899.80M |
| Q1 FY2004 | 31 Mar 2004 | 2.16 | 1.90B | 883.00M |
| Q4 FY2003 | 31 Dec 2003 | 2.07 | 1.78B | 860.50M |
| Q3 FY2003 | 30 Sept 2003 | 1.91 | 1.60B | 839.50M |
| Q2 FY2003 | 30 Jun 2003 | 2.37 | 1.90B | 799.20M |
| Q1 FY2003 | 31 Mar 2003 | 2.14 | 1.61B | 754.20M |
| Q4 FY2002 | 31 Dec 2002 | 2.12 | 1.50B | 704.00M |
| Q3 FY2002 | 30 Sept 2002 | 2.27 | 1.50B | 660.80M |
| Q2 FY2002 | 30 Jun 2002 | 2.01 | 1.29B | 642.80M |
| Q1 FY2002 | 31 Mar 2002 | 2.47 | 1.64B | 662.40M |
| Q4 FY2001 | 31 Dec 2001 | 2.36 | 1.63B | 692.00M |
| Q3 FY2001 | 30 Sept 2001 | 1.83 | 1.37B | 748.60M |
| Q2 FY2001 | 30 Jun 2001 | 1.97 | 1.55B | 786.60M |
| Q1 FY2001 | 31 Mar 2001 | 1.44 | 1.15B | 799.20M |
| Q4 FY2000 | 31 Dec 2000 | 1.24 | 1.03B | 833.30M |
| Q3 FY2000 | 30 Sept 2000 | 1.50 | 1.27B | 850.80M |
| Q2 FY2000 | 30 Jun 2000 | — | 1.08B | — |
| Q1 FY2000 | 31 Mar 2000 | — | 787.83M | — |
| Q4 FY1999 | 31 Dec 1999 | — | 958.47M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Edwards Lifesciences's P/S ratio
Source: Financial Modeling Prep